Research and Markets: Product and Pipeline Analysis of the Antibacterial Drugs Market 2015

Research and Markets (http://www.researchandmarkets.com/research/b9lrqd/a_product_and) has announced the addition of the "A Product and Pipeline Analysis of the Antibacterial Drugs Market " report to their offering.

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies.

This research service focuses on the global antibacterial drugs (antibiotics) market, with particular focus on the antibiotics currently under development. A list of currently available and marketed antibacterial drugs under the approved antibacterial drug classes has been provided. Product and pipeline assessment for recently approved antibacterial drugs, antibacterials under FDA review, as well as phase 3 antibacterial drug candidates have been provided. A detailed overview of the various regulatory approaches to foster innovation in the development of new antibiotics has been provided as well.

Antibacterial Drugs Listed

- Tedizolid Phosphate-Cubist Pharmaceuticals

- Dalbavancin (Dalvance)-Durata Therapeutics

- Ceftolozane + Tazobactam-Cubist Pharmaceuticals

- Oritavancin (Orbactiv)-The Medicines Company

- Ceftazidime + Avibactam (CAZ-AVI)-AstraZeneca

- Cadazolid-Actelion Pharmaceuticals

- Carbavance-Rempex Pharmaceuticals (The Medicines Company)

- Delafloxacin-Melinta Therapeutics

- Eravacycline-Tetraphase Pharmaceuticals

- Plazomicin-Achaogen

- Solithromycin-Cempra Pharmaceuticals

- Surotomycin-Cubist Pharmaceuticals

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Classification Of Antibacterial Drugs By Mechanism Of Action

4. Antibacterial Drugs Market-Pipeline Analysis

5. Antibacterial Drugs Market-Major Clinical Milestones

6. Antibacterial Drugs Market-Product Dashboard Of Recently Approved And Late-Stage Pipeline Drug Candidates

7. Antibiotic Resistance-A Critical Unmet Need That Poses Challenges To Antibiotic R&D

8. Antibacterial Drugs Market-Timeline Of Key Events

9. Regulatory Approaches To Stimulate Antibiotics R&D

10. Antibacterial Drugs Market-Key Companies To Watch

11. Conclusions

12. Appendix

Companies Mentioned

- Achaogen

- Actelion Pharmaceuticals

- AstraZeneca

- Cempra Pharmaceuticals

- Cubist Pharmaceuticals

- Durata Therapeutics

- Melinta Therapeutics

- Rempex Pharmaceuticals

- Tetraphase Pharmaceuticals

- The Medicines Company

For more information visit http://www.researchandmarkets.com/research/b9lrqd/a_product_and